Page last updated: 2024-10-22

amlodipine and Obstructive Lung Diseases

amlodipine has been researched along with Obstructive Lung Diseases in 1 studies

Amlodipine: A long-acting dihydropyridine calcium channel blocker. It is effective in the treatment of ANGINA PECTORIS and HYPERTENSION.
amlodipine : A fully substituted dialkyl 1,4-dihydropyridine-3,5-dicarboxylate derivative, which is used for the treatment of hypertension, chronic stable angina and confirmed or suspected vasospastic angina.

Research Excerpts

ExcerptRelevanceReference
" We have compared the pulmonary vasodilator effects, dose-response characteristics, and tolerability of two calcium channel blockers, amlodipine and extended-release (ER) felodipine, in 10 patients (seven men, age 68+/-4."2.68A comparison of two long-acting vasoselective calcium antagonists in pulmonary hypertension secondary to COPD. ( Alpers, JA; Bune, AJ; Frith, PA; McEvoy, RD; Sajkov, D; Wang, T, 1997)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sajkov, D1
Wang, T1
Frith, PA1
Bune, AJ1
Alpers, JA1
McEvoy, RD1

Trials

1 trial available for amlodipine and Obstructive Lung Diseases

ArticleYear
A comparison of two long-acting vasoselective calcium antagonists in pulmonary hypertension secondary to COPD.
    Chest, 1997, Volume: 111, Issue:6

    Topics: Aged; Amlodipine; Calcium Channel Blockers; Cross-Over Studies; Delayed-Action Preparations; Dose-Re

1997